Rhinovirus inhibition by bufadienolides.
- 1 January 1988
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 36 (1) , 326-332
- https://doi.org/10.1248/cpb.36.326
Abstract
An evaluation of thirty-four bufadienolides and two related cardenolides against a series of rhinoviruses in vitro has been completed. Most of the bufadienolides were found to display some inhibitory activity. Scillarenin and 3-O-[N-(tert-butoxycarbonyl)hydrazido] succinylbufalin were found to be the most active with chemotherapeutic indices of 32 and 16, respectively. In general, the 14.beta.-hydroxy-bufadienolides showed the strongest antiviral activity, and were found more toxic than the corresponding 14.beta.,15.beta.-epoxy-bufadienolides. Introduction of a 16.beta.-hydroxy or 16.beta.-acetoxy substituent into the 14.beta.,15.beta.-epoxybufadienolides enhanced their antiviral activity. Substituents at the 3.beta.-, 5.beta.-, and 19-positions appeared to affect only the level of toxicity.This publication has 4 references indexed in Scilit:
- Steroids and related natural products. 104. Bufadienolides. 36. Synthesis of bufalitoxin and bufotoxinThe Journal of Organic Chemistry, 1987
- Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDSJAMA, 1986
- EVIDENCE FOR HETEROSEXUAL TRANSMISSION AND CLINICAL MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND RELATED CONDITIONS IN LUSAKA, ZAMBIAThe Lancet, 1986
- Antiviral activity of natural occurring flavonoids in vitro.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985